Light Mode
$0.1532 ↓ -0.0001 (-0.07%) Trading Down from the previous close of $0.1533
-1.26 (-89.13%) / 6M
Momentum, market sentiment, and recent alerts
VIVS reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -93.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.